1.Preparation of Tetrandrine Solid Dispersion Tablets and Formulation Optimization
China Pharmacy 2016;27(7):949-951
OBJECTIVE:To optimize preparation formulation of Tetrandrine solid dispersion tablets. METHODS:Tetrandrine solid dispersion tablets were prepared by direct compression method. Excipients were screened with single factor test. Taking disinte-gration time as index,the formulation of Tetrandrine solid dispersion tablets was optimized by orthogonal design using the amount of PVPP,lactose-microcrystalline cellulose proportion and the amount of gum acacia as factors. The optimized formulation was vali-dated. Prepared tablets were compared with Tetrandrine common tablet in dissolution rate,and the contents of the tablets prepared by optimized formulation were also determined. RESULTS:Optimal formulation was as follows as 9.5% PVPP as disintegrating agent,lactose-microcrystalline cellulose(1∶2)as filler,mixing,1% aerosil as lubricant,direct compression. For 3 batches of tab-lets,disintegration time were 79,81 and 78 s;contents were 98.66%,99.24%,99.85%;RSDs were 0.72%,1.16%,1.33%,re-spectively. Combined with Tetrandrine common tablets,the dissolution rate of prepared tablets had been improved significantly. CONCLUSIONS:Tetrandrine solid dispersion tablets are prepared successfully with rational reproducible formulation.
2.Simultaneous Determination of Narirutin, Limonin, Honokiol and Magnolol in Zhishi Xiaopi Pills by HPLC
Jianwen XUE ; Hua LIN ; Xingzhen HUANG
China Pharmacist 2016;19(2):397-399
Objective:To establish an HPLC method for the simultaneous determination of narirutin, limonin, honokiol and mag-nolol in Zhishi Xiaopi pills. Methods:The separation was performed on a Shim-pack VP-ODS C18(250 mm ×4.6 mm,5 μm)column with the mobile phase consisting of acetonitrile–methanol(1 ∶2) (A) and water (B) with gradient elution. The flow rate was 1. 0 ml ·min-1 . The column temperature was 30℃. All the injection volume was 20 μl. Narirutin, limonin, honokiol and magnolol was de-tected at 283 nm, 210 nm, 294 nm and 294 nm, respectively. Results:Narirutin, limonin, honokiol and magnolol had good linearity within the concentration range of 5. 26-105. 20 μg·ml-1(r=0. 999 8), 7. 65-153. 00 μg·ml-1(r=0. 999 4), 6. 21-124. 20 μg· ml-1(r=0.999 3)and 6.45-129.00 μg·ml-1(r=0.999 6), respectively; the average recovery was 99.00%(RSD=0.77%), 98. 17%(RSD=1. 19%), 98. 78%(RSD=0. 86%) and 97. 90%(RSD=0. 99%), respectively. Conclusion: The method is sim-ple, rapid and reliable, which can be used for the quality control of Zhishi Xiaopi pills.
4.Effects of Panax Notoginseng Saponins Enteric-coated Pellets on Hemorheology in Rabbits
Shihua LU ; Lili WU ; Huagang LIU ; Ming CHEN ; Yan'e QIN ; Xingzhen HUANG ;
China Pharmacist 2017;20(4):658-660
Objective:To discuss the effects of panax notoginseng saponins (PNS) enteric-coated pellets on hemorrheology in rabbits.Methods:The rabbits were divided into the normal control group,the model control group,Xueshuangtong injection (lyophilization) group(15 mg·kg-1·d-1 ,im),PNS enteric-coated pellets groups respectively at high(45 mg·kg-1·d-1,ig),medium(30 mg·kg-1·d-1,ig) and low (15 mg·kg-1·d-1,ig) dose.The model was established by intragastric administration of high-fat diet.The whole-blood viscosity,plasma viscosity,erythrocyte aggregational index,crythrocyte index of rigidity and erythrocyte electro-phoresis rate in the groups were detected using hemorheological methods.Results:The above indices of hemorheology in the model control group were all significantly higher than those in the normal control group (P<0.01),suggesting the successful establishment of the model.Compared with the model control group,PNS enteric-coated pellets at high and medium doses could significantly reduce the whole blood viscosity and plasma viscosity(P<0.01 or P<0.05);PNS enteric-coated pellets group at low dose could significantly reduce the whole blood middle shear viscosity and plasma viscosity(P<0.05);the three PNS enteric-coated pellets groups could significantly reduce the agglutination index(P<0.01);PNS enteric-coated pellets at high and medium doses could significantly reduce the crythrocyte index of rigidity(P<0.01 or P<0.05);the three PNS enteric-coated pellets groups could significantly reduce the erythrocyte electro-phoresis rate,while there was no significant difference(P>0.05).Compared with Xueshuangtong injection (lyophilization) group,PNS enteric-coated pellets group at medium dose could significantly reduce the whole blood middle shear viscosity(P<0.05).Conclusion:PNS enteric-coated pellets can reduce the whole-blood viscosity,plasma viscosity,erythrocyte aggregational index,crythrocyte index of rigidity and erythrocyte electro-phoresis rate,and effectively promote blood circulation and remove stasis,inhibit thrombosis formation and increase blood supply for heart and cerebral vessels.
5.Stigma and related factors in family members of patients with mental disorders
Haiya SUN ; Huihui WEI ; Huimin GU ; Xingzhen JIN ; Sifang NIU ; Hao SUN ; Fuqin MU ; Ruixue XU ; Yueqin HUANG ; Wenjun WANG ; Yan LIU
Chinese Mental Health Journal 2023;37(12):1038-1044
Objective:To explore stigma and related factors among family members of patients with mental disorders in psychiatric hospitals.Methods:Totally 1 365 family members of inpatients with mental disorders were-surveyed,and were assessed with the Perceived Devaluation-Discrimination Scale and a self-made demographic characteristics questionnaire.Results:The screening rate of stigma among the patient's family members was 61.5%.Males(OR=2.26,95%CI:1.06-5.01),age group of 18-29 years(OR=1.91,95%CI:1.15-3.20),monthly income ≥500 yuan(P<0.05),disease duration of 0.5-<lyear(OR=3.14,95%CI:1.66-6.03),care for patients within<lyear(P<0.05),teachers(OR=2.32,95%CI:1.24-3.44),self-employed person(OR=1.63,95%CI:1.02-2.24),civil servants(OR=1.77,95%CI:1.09-2.45),schizophrenia(OR=1.87,95%CI:1.32-2.42),affective disorders(OR=1.52,95%CI:1.03-2.016)were the main riskfactors of stigma.Conclusions:Family members of patients with mental disorders generally have a severe stigma,especially of patients with schizophrenia and affective disorders.